NHS England Corrects Palantir Data Disclosure Following Criticism

NHS England has acknowledged and corrected an inaccuracy regarding the disclosure of patient data in its operating platform, which involves software from Palantir Technologies Inc.. The correction follows recent scrutiny concerning how the health service described the handling of information within the system.

Palantir builds and deploys software platforms designed to integrate with existing systems, providing tools for data analysis and decision support. While the company is widely known for its work with intelligence communities in the United States, the United Kingdom, and internationally—specifically for counterterrorism investigations—it has expanded into the healthcare and government services sectors. The company’s platforms are categorized under the software infrastructure industry.

The recent issue centers on the specific language used by NHS England regarding the management of patient-level data within the Federated Data Platform (FDP). The health service was reportedly criticized for initially providing an incorrect description of the data access controls, prompting an update to clarify the technical and operational details. This correction ensures that public documentation accurately reflects the data governance framework agreed upon with the technology provider.

As a publicly traded entity, Palantir continues to secure government contracts for its data integration capabilities. The company’s involvement with the NHS represents a significant civilian application of its technology, distinct from its traditional defense and intelligence roots.

Source: original release

What to watch

• Future updates from NHS England regarding the rollout of the Federated Data Platform.
• Palantir’s upcoming quarterly earnings report for details on government revenue growth.
• Any further announcements regarding data governance standards for public-private technology partnerships.